• Issue

    Journal of Thrombosis and Haemostasis: Volume 5, Issue 6

    1097-1344
    June 2007
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

REVIEW ARTICLES

Free Access

The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking

D. M. MONROE,  N. S. KEY, 
  • Pages: 1097-1105
  • First Published: 09 February 2007
Free Access

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

D. GAILANI,  T. RENNÉ, 
  • Pages: 1106-1112
  • First Published: 14 February 2007

COMMENTARIES

Free Access

von Willebrand disease: treatment with or without factor VIII?

B. A. KONKLE, 
  • Pages: 1113-1114
  • First Published: 31 March 2007
Free Access

Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?

G. D. O. LOWE, 
  • Pages: 1125-1127
  • First Published: 21 March 2007
Free Access

The bloody path of amyloids and prions

P. HAMMARSTRÖM, 
  • Pages: 1136-1138
  • First Published: 08 April 2007

IN FOCUS

Free Access

Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients

A. BOREL-DERLON,  A. B. FEDERICI,  V. ROUSSEL-ROBERT,  J. GOUDEMAND,  C. A. LEE,  I. SCHARRER,  C. ROTHSCHILD,  E. BERNTORP,  C. HENRIET,  Z. TELLIER,  F. BRIDEY,  P. M. MANNUCCI, 
  • Pages: 1115-1124
  • First Published: 31 March 2007
Free Access

Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study

N. A. ZAKAI,  R. KATZ,  N. S. JENNY,  B. M. PSATY,  A. P. REINER,  S. M. SCHWARTZ,  M. CUSHMAN, 
  • Pages: 1128-1135
  • First Published: 21 March 2007

IN FOCUS LETTER

Free Access

Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses

B. BOUMA,  C. MAAS,  B. P. C. HAZENBERG,  H. M. LOKHORST,  M. F. B. G. GEBBINK, 
  • Pages: 1139-1142
  • First Published: 20 February 2007

ORIGINAL ARTICLES

Clinical Studies

Free Access

Evidence of a U-shaped association between factor XII activity and overall survival

G. ENDLER,  C. MARSIK,  B. JILMA,  T. SCHICKBAUER,  P. QUEHENBERGER,  C. MANNHALTER, 
  • Pages: 1143-1148
  • First Published: 21 March 2007
Free Access

Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers

C. SABBÀ,  G. PASCULLI,  G. M. LENATO,  P. SUPPRESSA,  P. LASTELLA,  M. MEMEO,  F. DICUONZO,  G. GUANTI, 
  • Pages: 1149-1157
  • First Published: 21 March 2007
Free Access

Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study

N. BIZZARO,  A. GHIRARDELLO,  S. ZAMPIERI,  L. IACCARINO,  R. TOZZOLI,  A. RUFFATTI,  D. VILLALTA,  E. TONUTTI,  A. DORIA, 
  • Pages: 1158-1164
  • First Published: 21 March 2007
Free Access

Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease

A. H. JAMES,  M. G. JAMISON, 
  • Pages: 1165-1169
  • First Published: 31 March 2007
Free Access

Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin

P. PIGNATELLI,  V. SANGUIGNI,  L. LENTI,  L. LOFFREDO,  R. CARNEVALE,  R. SORGE,  F. VIOLI, 
  • Pages: 1170-1178
  • First Published: 21 March 2007
Free Access

Role of elevated α2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism

A. BEHEIRI,  C. LANGER,  C. DÜRING,  A. KRÜMPEL,  S. THEDIECK,  U. NOWAK-GÖTTL, 
  • Pages: 1179-1184
  • First Published: 22 March 2007
Free Access

High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses

C. R. KEENAN,  S. MURIN,  R. H. WHITE, 
  • Pages: 1185-1190
  • First Published: 31 March 2007
Free Access

Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials

B. L. DAVIDSON,  H. R. BÜLLER,  H. DECOUSUS,  A. GALLUS,  M. GENT,  F. PIOVELLA,  M. H. PRINS,  G. E. RASKOB,  A. E. M. SEGERS,  A. W. A. LENSING,  FOR THE MATISSE INVESTIGATORS , 
  • Pages: 1191-1194
  • First Published: 31 March 2007

Free Access

A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects

M. U. Zafar,  G. VILAHUR,  B. G. CHOI,  B. IBANEZ,  J. F. VILES-GONZALEZ,  E. SALAS,  J. J. BADIMON, 
  • Pages: 1195-1200
  • First Published: 27 March 2007
Free Access

Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis

C. VIGEN,  H. N. HODIS,  W. L. CHANDLER,  R. A. LOBO,  W. J. MACK, 
  • Pages: 1201-1208
  • First Published: 27 March 2007
Free Access

Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions

R.-M. GUÉANT-RODRIGUEZ,  Y. JUILLIÈRE,  M. NIPPERT,  I. ABDELMOUTTALEB,  B. HERBETH,  E. ALIOT,  N. DANCHIN,  J.-L. GUÉANT, 
  • Pages: 1209-1216
  • First Published: 22 March 2007

Coagulation

Free Access

Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet–leukocyte activation: role of P-selectin

A. NEMMAR,  P. H. M. HOET,  P. VANDERVOORT,  D. DINSDALE,  B. NEMERY,  M. F. HOYLAERTS, 
  • Pages: 1217-1226
  • First Published: 31 March 2007
Free Access

Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer

E. F. COHN,  J. ZHUO,  M. E. KELLY,  H. J. CHAO, 
  • Pages: 1227-1236
  • First Published: 14 March 2007
Free Access

Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis

W. WIENEN,  J.-M. STASSEN,  H. PRIEPKE,  U. J. RIES,  N. HAUEL, 
  • Pages: 1237-1242
  • First Published: 14 March 2007
Free Access

Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio

S. UITTE DE WILLIGE,  I. M. RIETVELD,  M. C. H. DE VISSER,  H. L. VOS,  R. M. BERTINA, 
  • Pages: 1243-1249
  • First Published: 31 March 2007

Fibrinolysis

Free Access

The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease

P. Y. KIM,  R. J. STEWART,  S. M. LIPSON,  M. E. NESHEIM, 
  • Pages: 1250-1256
  • First Published: 31 January 2007
Free Access

Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors

J. B. WALKER,  L. BAJZAR, 
  • Pages: 1257-1264
  • First Published: 27 March 2007
Open Access

Fibrinolysis in a lipid environment: modulation through release of free fatty acids

G. RÁBAI,  B. VÁRADI,  C. LONGSTAFF,  P. SÓTONYI,  V. KRISTÓF,  F. TIMÁR,  R. MACHOVICH,  K. KOLEV, 
  • Pages: 1265-1273
  • First Published: 31 March 2007

Platelets

Free Access

Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL

Y. KOZUMA,  H. KOJIMA,  S. YUKI,  H. SUZUKI,  T. NAGASAWA, 
  • Pages: 1274-1282
  • First Published: 27 March 2007
Free Access

Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets

J. J. LOPEZ,  G. M. SALIDO,  E. GÓMEZ-ARTETA,  J. A. ROSADO,  J. A. PARIENTE, 
  • Pages: 1283-1291
  • First Published: 07 March 2007

Vascular Biology

Free Access

The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins α5β1 and αvβ3

S. AOKI,  Y. YATOMI,  T. SHIMOSAWA,  H. YAMASHITA,  J. KITAYAMA,  N. H. TSUNO,  K. TAKAHASHI,  Y. OZAKI, 
  • Pages: 1292-1301
  • First Published: 31 March 2007
Free Access

The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells

L. DOU,  N. JOURDE-CHICHE,  V. FAURE,  C. CERINI,  Y. BERLAND,  F. DIGNAT-GEORGE,  P. BRUNET, 
  • Pages: 1302-1308
  • First Published: 22 March 2007
Free Access

Effect of wine phenolics on cytokine-induced C-reactive protein expression

G. KAUR,  L. V. M. RAO,  A. AGRAWAL,  U. R. PENDURTHI, 
  • Pages: 1309-1317
  • First Published: 21 March 2007

OFFICIAL COMMUNICATION OF THE SSC

Free Access

Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116)1

A. R. HUBBARD,  L. J. WELLER,  S. JOHNES,  ON BEHALF OF THE SSC SUBCOMMITTEE ON FACTOR VIII AND FACTOR IX OF THE ISTH , 
  • Pages: 1318-1319
  • First Published: 31 March 2007

LETTERS TO THE EDITOR

Free Access

Local tissue-type plasminogen activator release in patients with ischemic stroke

K. JOOD,  C. JERN,  C. BLOMSTRAND,  S. JERN,  T. HRAFNKELSDÓTTIR, 
  • Pages: 1320-1322
  • First Published: 31 March 2007
Free Access

Thalidomide causes platelet activation, which can be abrogated by aspirin

S. DUNKLEY,  L. GAUDRY, 
  • Pages: 1323-1324
  • First Published: 27 March 2007
Free Access

Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z

C. Y. VOSSEN,  S. J. HASSTEDT,  C. DEMERS,  F. R. ROSENDAAL,  E. G. BOVILL, 
  • Pages: 1325-1326
  • First Published: 31 March 2007
Free Access

Feasibility and accuracy of a rapid ‘point-of-care’ D-dimer test performed with a capillary blood sample

E. F. VAN DER VELDE,  I. M. WICHERS,  D. B. TOLL,  H. C. P. M. VAN WEERT,  H. R. BÜLLER, 
  • Pages: 1327-1329
  • First Published: 31 March 2007
Free Access

Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay

C. M. ECKMANN,  R. T. M. DE LAAF,  J. M. VAN KEULEN,  J. A. VAN MOURIK,  B. DE LAAT, 
  • Pages: 1330-1331
  • First Published: 12 March 2007
Free Access

A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges

D. J. MEIER,  S. SEVA,  W. P. FAY, 
  • Pages: 1332-1333
  • First Published: 31 March 2007
Free Access

The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal

J. L. WILLEMSE,  E. HEYLEN,  D. F. HENDRIKS, 
  • Pages: 1334-1336
  • First Published: 22 March 2007
Free Access

The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal

Z. VALNICKOVA,  I. B. THØGERSEN,  J. POTEMPA,  J. J. ENGHILD, 
  • Pages: 1336-1337
  • First Published: 18 April 2007
Free Access

A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen-type-specific contributions to adhesion: a rebuttal

T. LISMAN,  R. W. FARNDALE,  P. G. DE GROOT, 
  • Pages: 1338-1339
  • First Published: 22 March 2007
Free Access

A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor-glycoprotein Ib and integrin α2β1-collagen interactions make complementary, collagen-type-specific contributions to adhesion: reply to a rebuttal

M. MOROI,  S. M. JUNG, 
  • Pages: 1340-1342
  • First Published: 31 March 2007

CORRIGENDUM

Free Access

Corrigendum

  • Page: 1343
  • First Published: 26 May 2007

ANNOUNCEMENTS

Free Access

ANNOUNCEMENTS

  • Page: 1344
  • First Published: 26 May 2007